Innocan Pharma Corp
F:IP4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innocan Pharma Corp
F:IP4
|
IL |
|
E
|
Eastern Media International Corp
TWSE:2614
|
TW |
|
Abivax SA
LSE:0RA9
|
FR |
Intrinsic Value
The intrinsic value for Innocan Pharma Corp (IP4) under the Base Case is 16.9 EUR. Compared with the current market price of 11.7 EUR, the stock appears Undervalued by 31% .
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Innocan Pharma Corp.
The intrinsic value for Innocan Pharma Corp (IP4) under the Base Case is 16.9 EUR.
Compared with the current market price of 11.7 EUR, the stock appears Undervalued by 31% .